drugset
drugset / Trial / NCT02391636

Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage

NCT02391636 ↗

Phase 4 Completed 264 enrolled Ghamra Military Hospital Ain Shams Maternity Hospital · collab
RandomizedParallel-groupDouble-blindPrevention

Summary

Double blinded randomized controlled study

Timeline

Start
2015-02
Primary completion
2016-09
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 100 ug Intravenous
Comparator Oxytocin Peptide 5 iu Intravenous

Indications

No indication recorded.